US 9676846
Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
granted A61KA61K2039/505
Quick answer
US patent 9676846 (Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K2039/505